AR and polycystic ovary syndrome: An increased immunoreactive signal was observed in the PCOS-like rats, but the AR-positive areas in the DSM 27449 and Diane-35 groups were significantly lower than those in the letrozole group (Figure 3C, Letrozole vs. DSM 27449, p = 0.0050; Letrozole vs. Diane-35, p = 0.0004).